Monday: AbbVie abandons Galapagos phase III and stock plummets 39% (and still dropping)
Tuesday: Will Roche lose it’s Worldwide Leading position in Cancer treatments?
Wednesday: CRISPR Patent war to End after the Discovery of a New Editing Protein other than Cas9?
Thursday: Artificially Intelligent ‘Betsy’ will analyse 100,000 genomes for UK Government
Friday: Merck relinquishes Rare Disease license to instead focus on Immuno-oncology
Weekend: We will celebrate German unity on Saturday.
Content continues below